{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:49:01Z","timestamp":1790711341166,"version":"4.1.0"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/ajg.2014.21","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T08:10:59Z","timestamp":1392711059000},"page":"796-809","source":"Crossref","is-referenced-by-count":78,"title":["FibroTest\/Fibrosure for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis"],"prefix":"10.14309","volume":"109","author":[{"given":"Nermin N","family":"Salkic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Predrag","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majda","family":"Brcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210210","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3748\/wjg.v12.i23.3682","article-title":"Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.","volume":"12","author":"Sebastiani","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R3-5-20210210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"R4-5-20210210","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","article-title":"Chronic hepatitis B.","volume":"34","author":"Lok","year":"2001","journal-title":"Hepatology"},{"key":"R5-5-20210210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jhep.2000.16602","article-title":"Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).","volume":"32","author":"Cadranel","year":"2000","journal-title":"Hepatology"},{"key":"R6-5-20210210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000071293","article-title":"Bleeding complications after percutaneous liver biopsy. An analysis of risk factors.","volume":"67","author":"Terjung","year":"2003","journal-title":"Digestion"},{"key":"R7-5-20210210","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2010.06.015","article-title":"Reduced mortality rates following elective percutaneous liver biopsies.","volume":"139","author":"West","year":"2010","journal-title":"Gastroenterology"},{"key":"R8-5-20210210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jhep.2003.11.008","article-title":"Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis.","volume":"40","author":"Brunetti","year":"2004","journal-title":"J Hepatol"},{"key":"R9-5-20210210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8278(03)00191-0","article-title":"Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease.","volume":"39","author":"Colloredo","year":"2003","journal-title":"J Hepatol"},{"key":"R10-5-20210210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.20535","article-title":"Sources of variability in histological scoring of chronic viral hepatitis.","volume":"41","author":"Rousselet","year":"2005","journal-title":"Hepatology"},{"key":"R11-5-20210210","first-page":"1293","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C.","volume":"142","author":"Castera","year":"2012","journal-title":"YGAST"},{"key":"R12-5-20210210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C.","volume":"20","year":"1994","journal-title":"Hepatology"},{"key":"R13-5-20210210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpgasthep1025","article-title":"Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.","volume":"5","author":"Pinzani","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"R14-5-20210210","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"R15-5-20210210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-5926-3-8","article-title":"Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.","volume":"3","author":"Poynard","year":"2004","journal-title":"Comp Hepatol"},{"key":"R16-5-20210210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clinbiochem.2007.08.009","article-title":"Reproducibility of blood tests of liver fibrosis in clinical practice.","volume":"41","author":"Cales","year":"2008","journal-title":"Clin Biochem"},{"key":"R17-5-20210210","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1373\/clinchem.2004.032227","article-title":"Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.","volume":"50","author":"Poynard","year":"2004","journal-title":"Clin Chem"},{"key":"R18-5-20210210","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1002\/hep.21046","article-title":"Noninvasive measures of liver fibrosis.","volume":"43","author":"Rockey","year":"2006","journal-title":"Hepatology"},{"key":"R19-5-20210210","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0399-8320(08)73991-5","article-title":"FibroTest-ActiTest as a non-invasive marker of liver fibrosis.","volume":"32","author":"Halfon","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"R20-5-20210210","doi-asserted-by":"crossref","first-page":"e30325","DOI":"10.1371\/journal.pone.0030325","article-title":"Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data.","volume":"7","author":"Poynard","year":"2012","journal-title":"PloS One"},{"key":"R21-5-20210210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-7-40","article-title":"Meta-analyses of FibroTest diagnostic value in chronic liver disease.","volume":"7","author":"Poynard","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"R22-5-20210210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11901-011-0096-0","article-title":"Noninvasive markers of hepatic fibrosis in chronic hepatitis B.","volume":"10","author":"Poynard","year":"2011","journal-title":"Curr Hepat Rep"},{"key":"R23-5-20210210","first-page":"445","article-title":"Prognostic value of liver fibrosis biomarkers: a meta-analysis.","volume":"7","author":"Poynard","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"R24-5-20210210","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/j.1572-0241.2007.01466.x","article-title":"FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.","volume":"102","author":"Shaheen","year":"2007","journal-title":"Am J Gastroenterols"},{"key":"R27-5-20210210","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"R30-5-20210210","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","article-title":"Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages.","volume":"53","author":"Poynard","year":"2007","journal-title":"Clin Chem"},{"key":"R32-5-20210210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.24013","article-title":"Noninvasive assessment of liver fibrosis.","volume":"53","author":"Martinez","year":"2011","journal-title":"Hepatology"},{"key":"R33-5-20210210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"R34-5-20210210","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.","volume":"58","author":"Deeks","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"R35-5-20210210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/MEG.0b013e328332dd0a","article-title":"Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.","volume":"22","author":"Anastasiou","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R36-5-20210210","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1478-3231.2009.02101.x","article-title":"The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.","volume":"29","author":"Boursier","year":"2009","journal-title":"Liver Int"},{"key":"R37-5-20210210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jcla.21554","article-title":"Study on noninvasive laboratory tests for fibrosis in chronic HBV infection and their evaluation.","volume":"27","author":"Chen","year":"2013","journal-title":"J Clin Lab Anal"},{"key":"R38-5-20210210","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/apt.12307","article-title":"Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus.","volume":"37","author":"de Ledinghen","year":"2013","journal-title":"Alim Pharmacol Ther"},{"key":"R39-5-20210210","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2010.05.035","article-title":"Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).","volume":"53","author":"Degos","year":"2010","journal-title":"J Hepatol"},{"key":"R40-5-20210210","first-page":"83","article-title":"Fibroscan and FibroTestFibroMax to assess liver fibrosiscirrhosis in patients with chronic HBV and HCV infection in Georgia.","volume":"165","author":"Dolmazashvili","year":"2008","journal-title":"Georgian Med News"},{"key":"R41-5-20210210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-230X-10-103","article-title":"Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis.","volume":"10","author":"Friedrich-Rust","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"R42-5-20210210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-0028-1109488","article-title":"Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease.","volume":"30","author":"Friedrich-Rust","year":"2009","journal-title":"Ultraschall Med"},{"key":"R43-5-20210210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.2008.03895.x","article-title":"The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B.","volume":"29","author":"Mallet","year":"2009","journal-title":"Alim Pharmacol Ther"},{"key":"R44-5-20210210","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0377-4929.68281","article-title":"Comparison of FibroTest-ActiTest with histopathology in demonstrating fibrosis and necroinflammatory activity in chronic hepatitis B and C.","volume":"53","author":"Uyar","year":"2010","journal-title":"Indian J Pathol Microbiol"},{"key":"R45-5-20210210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1148\/radiol.13122208","article-title":"Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography-comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.","volume":"269","author":"Cassinotto","year":"2013","journal-title":"Radiology"},{"key":"R46-5-20210210","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(03)00171-5","article-title":"Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.","volume":"39","author":"Myers","year":"2003","journal-title":"J Hepatol"},{"key":"R47-5-20210210","first-page":"1274","article-title":"Validation of Fibrotest to diagnose liver fibrosis to patients with chronic hepatitis B.","volume":"27","author":"Zhao","year":"2007","journal-title":"Chinese J Pract Int Med"},{"key":"R48-5-20210210","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3748\/wjg.v13.i4.525","article-title":"Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.","volume":"13","author":"Sebastiani","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R49-5-20210210","first-page":"897","article-title":"FibroTest-ActiTest for predicting liver fibrosis and inflammatory activity in Chinese patients with chronic hepatitis B.","volume":"16","author":"Gui","year":"2008","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R50-5-20210210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2893.2008.01065.x","article-title":"Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus.","volume":"16","author":"Poynard","year":"2009","journal-title":"J Viral Hepat"},{"key":"R51-5-20210210","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jhep.2009.01.022","article-title":"Performance of 11 biomarkers for liver fibrosis assessment in HIVHBV co-infected patients.","volume":"50","author":"Bottero","year":"2009","journal-title":"J Hepatol"},{"key":"R52-5-20210210","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4269\/ajtmh.2010.09-0088","article-title":"Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.","volume":"82","author":"Bonnard","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"R53-5-20210210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2036.2010.04547.x","article-title":"Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.","volume":"33","author":"Castera","year":"2011","journal-title":"Alim Pharmacol Ther"},{"key":"R54-5-20210210","doi-asserted-by":"crossref","first-page":"e22291","DOI":"10.1371\/journal.pone.0022291","article-title":"Liver stiffness measurement and biochemical markers in senegalese chronic Hepatitis B patients with normal ALT and high viral load.","volume":"6","author":"Mbaye","year":"2011","journal-title":"PloS one"},{"key":"R55-5-20210210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2893.2010.01275.x","article-title":"Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIVHBV-coinfected patients.","volume":"18","author":"Miailhes","year":"2011","journal-title":"J Viral Hepat"},{"key":"R56-5-20210210","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/00365521.2011.574725","article-title":"Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.","volume":"46","author":"Stibbe","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"R57-5-20210210","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12072-011-9296-5","article-title":"Comparison of noninvasive models of fibrosis in chronic hepatitis B.","volume":"6","author":"Raftopoulos","year":"2011","journal-title":"Hepatol Int"},{"key":"R58-5-20210210","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1365-2036.2011.04861.x","article-title":"The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.","volume":"34","author":"Sebastiani","year":"2011","journal-title":"Alim Pharmacol Ther"},{"key":"R59-5-20210210","doi-asserted-by":"crossref","first-page":"e41964","DOI":"10.1371\/journal.pone.0041964","article-title":"Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.","volume":"7","author":"Kim","year":"2012","journal-title":"PloS One"},{"key":"R60-5-20210210","doi-asserted-by":"crossref","first-page":"e35825","DOI":"10.1371\/journal.pone.0035825","article-title":"Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.","volume":"7","author":"Kim","year":"2012","journal-title":"PloS One"},{"key":"R61-5-20210210","doi-asserted-by":"crossref","first-page":"e55759","DOI":"10.1371\/journal.pone.0055759","article-title":"Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.","volume":"8","author":"Park","year":"2013","journal-title":"PloS One"},{"key":"R63-5-20210210","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R64-5-20210210","first-page":"541","article-title":"Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.","volume":"100","author":"Poynard","year":"2012","journal-title":"J Hepatol"},{"key":"R65-5-20210210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jhep.2008.07.039","article-title":"Exceeding the limits of liver histology markers.","volume":"50","author":"Mehta","year":"2009","journal-title":"J Hepatol"},{"key":"R66-5-20210210","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(86)90883-4","article-title":"Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.","volume":"1","author":"Maharaj","year":"1986","journal-title":"Lancet"},{"key":"R67-5-20210210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2006.09.020","article-title":"Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.","volume":"46","author":"Halfon","year":"2007","journal-title":"J Hepatol"},{"key":"R68-5-20210210","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/jhep.2003.09022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C.","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"R69-5-20210210","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1373\/clinchem.2007.096032","article-title":"Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions.","volume":"54","author":"Leeflang","year":"2008","journal-title":"Clin Chem"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg201421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg201421","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg201421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201406000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:01:47Z","timestamp":1786543307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201406000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2014.21","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}